BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Galleon Pharmaceuticals, Inc. 

3701 Market Street
5th Floor
Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 609-658-1008 Fax: 609-275-6781


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Galleon Pharmaceuticals, Inc. Scientists Win Prestigious Research Awards For First-In-Class Treatment Of Emerging Perioperative Sleep Apnea Epidemic 1/6/2014 9:46:39 AM    More...
Galleon Pharmaceuticals, Inc. Demonstrates Successful Clinical Proof-of-Concept for Lead Product From Sleep Apnea Drug-Discovery Platform 4/11/2013 12:10:44 PM    More...
Galleon Pharmaceuticals, Inc. Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression 9/20/2012 10:24:35 AM    More...
Galleon Pharmaceuticals, Inc. Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression 5/7/2012 9:57:55 AM    More...
Galleon Pharmaceuticals, Inc. Reports Positive Results from Phase I Study of GAL-021 for Treatment of Respiratory Depression 5/7/2012 7:42:20 AM    More...
Galleon Pharmaceuticals, Inc. Names Lynne Brookes Senior Vice President and Chief Business Officer 12/1/2011 10:18:17 AM    More...
Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals, Inc. 10/26/2011 11:52:51 AM    More...
Stealthy Galleon Pharmaceuticals, Inc. Sails With $15 Million 12/30/2008 8:44:32 AM    More...

//-->